White matter hyperintensities and amyloid are independently associated with entorhinal cortex volume among individuals with mild cognitive impairment
暂无分享,去创建一个
Owen T. Carmichael | Adam M. Brickman | Giuseppe Tosto | Christopher Schwarz | Molly E. Zimmerman | Owen Carmichael | A. Brickman | C. Schwarz | M. Zimmerman | G. Tosto | V. Guzman | Vanessa A. Guzman
[1] Evan Fletcher,et al. Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume , 2012, Neurobiology of Aging.
[2] Olivier Colliot,et al. CSF tau markers are correlated with hippocampal volume in Alzheimer's disease , 2012, Neurobiology of Aging.
[3] J. Price,et al. Mild cognitive impairment represents early-stage Alzheimer disease. , 2001, Archives of neurology.
[4] C. DeCarli,et al. What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? , 2007, Neurology.
[5] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[6] Kyle Steenland,et al. Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease. , 2006, Clinical therapeutics.
[7] Cindee M. Madison,et al. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. , 2009, Brain : a journal of neurology.
[8] D. Delis,et al. Quantification of five neuropsychological approaches to defining mild cognitive impairment. , 2009, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[9] Clifford R Jack,et al. Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. , 2012, Radiology.
[10] D. Rueckert,et al. Multi-Method Analysis of MRI Images in Early Diagnostics of Alzheimer's Disease , 2011, PloS one.
[11] Menno P. Witter,et al. A pathophysiological framework of hippocampal dysfunction in ageing and disease , 2011, Nature Reviews Neuroscience.
[12] Nick C Fox,et al. The Alzheimer's disease neuroimaging initiative (ADNI): MRI methods , 2008, Journal of magnetic resonance imaging : JMRI.
[13] Frederik Barkhof,et al. Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study , 2010, Neurobiology of Aging.
[14] Alan C. Evans,et al. Correlation of cerebrospinal fluid levels of tau protein phosphorylated at threonine 231 with rates of hippocampal atrophy in Alzheimer disease. , 2005, Archives of neurology.
[15] S. Leurgans,et al. MRI-derived entorhinal volume is a good predictor of conversion from MCI to AD , 2004, Neurobiology of Aging.
[16] H. Soininen,et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. , 2009, Archives of neurology.
[17] M. D. O'Brien,et al. Cerebral blood flow in dementia , 1986, Neurology.
[18] Murray Grossman,et al. CSF biomarkers cutoffs: the importance of coincident neuropathological diseases , 2012, Acta Neuropathologica.
[19] Hilkka Soininen,et al. CSF Abeta42, tau and phosphorylated tau correlate with medial temporal lobe atrophy. , 2008, Journal of Alzheimer's disease : JAD.
[20] R. Petersen,et al. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.
[21] W. M. van der Flier,et al. Shifting Paradigms in Dementia , 2007, Annals of the New York Academy of Sciences.
[22] S. Leurgans,et al. MRI predictors of risk of incident Alzheimer disease , 2005, Neurology.
[23] Evan Fletcher,et al. Fully-Automated White Matter Hyperintensity Detection with Anatomical Prior Knowledge and without FLAIR , 2009, IPMI.
[24] C. Jack,et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade , 2010, The Lancet Neurology.
[25] B. Reisberg,et al. Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairment , 2006, Neurobiology of Aging.
[26] Jordan Muraskin,et al. Structural neuroimaging in Alzheimer's disease: do white matter hyperintensities matter? , 2009, Dialogues in clinical neuroscience.
[27] Vijaya L. Melnick,et al. Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.
[28] Dominic Holland,et al. Amyloid‐β associated volume loss occurs only in the presence of phospho‐tau , 2011, Annals of neurology.
[29] V. Leirer,et al. Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.
[30] D. Harvey,et al. Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD , 2006, Neurology.
[31] David A. Bennett,et al. Mixed brain pathologies account for most dementia cases in community-dwelling older persons , 2007, Neurology.
[32] Yaakov Stern,et al. Measuring cerebral atrophy and white matter hyperintensity burden to predict the rate of cognitive decline in Alzheimer disease. , 2008, Archives of neurology.
[33] D. Teichberg,et al. Local histogram correction of MRI spatially dependent image pixel intensity nonuniformity , 1996, Journal of magnetic resonance imaging : JMRI.
[34] Daniel Rueckert,et al. Nonrigid registration using free-form deformations: application to breast MR images , 1999, IEEE Transactions on Medical Imaging.
[35] Hilkka Soininen,et al. J-ADNI and selection of cognition measures , 2010, Alzheimer's & Dementia.
[36] Amity E. Green,et al. 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects , 2010, Neurobiology of Aging.
[37] A. Brickman,et al. Regional white matter hyperintensity volume, not hippocampal atrophy, predicts incident Alzheimer disease in the community. , 2012, Archives of neurology.
[38] Kathleen A. Welsh-Bohmer,et al. Geriatric neuropsychology : assessment and intervention , 2006 .
[39] S. Leurgans,et al. The neuropathology of probable Alzheimer disease and mild cognitive impairment , 2009, Annals of neurology.
[40] H. Soininen,et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. , 2006, Brain : a journal of neurology.
[41] D. Galimberti,et al. Faculty Opinions recommendation of Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. , 2009 .
[42] Robert A. Dean,et al. Qualification of the analytical and clinical performance of CSF biomarker analyses in ADNI , 2011, Acta Neuropathologica.